MaxCyte, Inc. (MXCT)
1.35
+0.04
(+3.05%)
USD |
NASDAQ |
Nov 06, 10:14
MaxCyte Gross Profit Margin (Quarterly) : 63.86% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.86% |
| March 31, 2026 | 73.22% |
| December 31, 2025 | 63.68% |
| September 30, 2025 | 61.34% |
| June 30, 2025 | 69.45% |
| March 31, 2025 | 75.38% |
| December 31, 2024 | 62.03% |
| September 30, 2024 | 63.88% |
| June 30, 2024 | 75.82% |
| March 31, 2024 | 78.21% |
| December 31, 2023 | 83.17% |
| Date | Value |
|---|---|
| September 30, 2023 | 77.19% |
| June 30, 2023 | 73.98% |
| March 31, 2023 | 77.71% |
| December 31, 2022 | 80.52% |
| September 30, 2022 | 80.47% |
| June 30, 2022 | 83.16% |
| March 31, 2022 | 86.97% |
| December 31, 2021 | 83.82% |
| September 30, 2021 | 90.69% |
| June 30, 2021 | 88.96% |
| March 31, 2021 | 89.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 47.78% |
| Azenta, Inc. | 44.89% |
| Danaher Corp. | 59.34% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.50% |
| Return on Assets | -17.56% |
| Return on Invested Capital | -18.59% |
| Profit Margin (Quarterly) | -122.0% |
| Operating Margin (Quarterly) | -111.2% |
| Return on Net Operating Assets | -82.21% |